|
1
|
Asaga S, Kuo C, Nguyen T, et al: Direct
serum assay for microRNA-21 concentrations in early and advanced
breast cancer. Clin Chem. 57:84–91. 2011. View Article : Google Scholar
|
|
2
|
Heneghan HM, Miller N, Lowery AJ, et al:
MicroRNAs as novel biomarkers for breast cancer. J Oncol.
2009:9502012009.PubMed/NCBI
|
|
3
|
Roth C, Rack B, Müller V, et al:
Circulating microRNAs as blood-based markers for patients with
primary and metastatic breast cancer. Breast Cancer Res.
12:R902010. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar
|
|
5
|
Zhao B, Han H, Chen J, et al: MicroRNA
let-7c inhibits migration and invasion of human non-small cell lung
cancer by targeting ITGB3 and MAP4K3. Cancer Lett. 342:43–51. 2014.
View Article : Google Scholar
|
|
6
|
Sempere LF, Freemantle S, Pitha-Rowe I, et
al: Expression profiling of mammalian microRNAs uncovers a subset
of brain-expressed microRNAs with possible roles in murine and
human neuronal differentiation. Genome Biol. 5:R132004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pelosi A, Careccia S, Lulli V, et al:
miRNA let-7c promotes granulocytic differentiation in acute myeloid
leukemia. Oncogene. 32:3648–3654. 2013. View Article : Google Scholar
|
|
8
|
Qian B, Katsaros D, Lu L, et al: High
miR-21 expression in breast cancer associated with poor
disease-free survival in early stage disease and high TGF-beta1.
Breast Cancer Res Treat. 117:131–140. 2009. View Article : Google Scholar
|
|
9
|
Wang PY, Sun YX, Zhang S, et al: Let-7c
inhibits A549 cell proliferation through oncogenic TRIB2 related
factors. FEBS Lett. 587:2675–2681. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Q, Wang C, Lu Z, Guo L and Ge Q:
Analysis of serum genome-wide microRNAs for breast cancer
detection. Clin Chim Acta. 413:1058–1065. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Ba Y, Ma L, et al:
Characterization of microRNAs in serum: a novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang HH, Pang M, Dong W, et al: miR-511
induces the apoptosis of radioresistant lung adenocarcinoma cells
by triggering BAX. Oncol Rep. 31:1473–1479. 2014.PubMed/NCBI
|
|
13
|
Wang PY, Sun YX, Zhang S, et al: Let-7c
inhibits A549 cell proliferation through oncogenic TRIB2 related
factors. FEBS Lett. 587:2675–2681. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu X, Guo J, Zheng L, et al: The
heterochronic microRNA let-7 inhibits cell motility by regulating
the genes in the actin cytoskeleton pathway in breast cancer. Mol
Cancer Res. 11:240–250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Piskounova E, Polytarchou C, Thornton JE,
et al: Lin28A and Lin28B inhibit let-7 microRNA biogenesis by
distinct mechanisms. Cell. 147:1066–1079. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui X, Schiff R, Arpino G, Osborne CK and
Lee AV: Biology of progesterone receptor loss in breast cancer and
its implications for endocrine therapy. J Clin Oncol. 23:7721–7735.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Diaz NM: Laboratory testing for HER2/neu
in breast carcinoma: an evolving strategy to predict response to
targeted therapy. Cancer Control. 8:415–418. 2001.PubMed/NCBI
|
|
18
|
Kerlikowske K, Cook AJ, Buist DS, et al:
Breast cancer risk by breast density, menopause and postmenopausal
hormone therapy use. J Clin Oncol. 28:3830–3837. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qin B, Xiao B, Liang D, et al: MicroRNA
let-7c inhibits Bcl-xl expression and regulates ox-LDL-induced
endothelial apoptosis. BMB Rep. 45:464–469. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Johnson SM, Grosshans H, Shingara J, et
al: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jones CI, Zabolotskaya MV, King AJ, et al:
Identification of circulating microRNAs as diagnostic biomarkers
for use in multiple myeloma. Br J Cancer. 107:1987–1996. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakurai M, Miki Y, Masuda M, et al: LIN28:
a regulator of tumor-suppressing activity of let-7 microRNA in
human breast cancer. J Steroid Biochem Mol Biol. 131:101–106. 2012.
View Article : Google Scholar
|
|
23
|
Zhu XM, Wu LJ, Xu J, Yang R and Wu FS:
Let-7c microRNA expression and clinical significance in
hepatocellular carcinoma. J Int Med Res. 39:2323–2329. 2011.
View Article : Google Scholar
|
|
24
|
Shimizu S, Takehara T, Hikita H, et al:
The let-7 family of microRNAs inhibits Bcl-xL expression and
potentiates sorafenib-induced apoptosis in human hepatocellular
carcinoma. J Hepatol. 52:698–704. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Björner S, Fitzpatrick PA, Li Y, et al:
Epithelial and stromal microRNA signatures of columnar cell
hyperplasia linking Let-7c to precancerous and cancerous breast
cancer cell proliferation. PLoS One. 9:e1050992014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barnes DM and Hanby AM: Oestrogen and
progesterone receptors in breast cancer: past, present and future.
Histopathology. 38:271–274. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sofi GN, Sofi JN, Nadeem R, et al:
Estrogen receptor and progesterone receptor status in breast cancer
in relation to age, histological grade, size of lesion and lymph
node involvement. Asian Pac J Cancer Prev. 13:5047–5052. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Faheem M, Mahmood H, Khurram M, Qasim U
and Irfan J: Estrogen receptor, progesterone receptor and Her 2 Neu
positivity and its association with tumour characteristics and
menopausal status in a breast cancer cohort from northern Pakistan.
Ecancermedicalscience. 6:2832012.
|
